AMPLATZER PRO OCCLUDER (PFO)

Quick Overview

For patients who have had a cryptogenic stroke and have a patent foramen ovale (PFO), clinical trials have shown that they can benefit from PFO closure.2-4 The Amplatzer PFO occluder significantly lowers the risk of recurrent ischemic stroke, and furthermore it offers an excellent safety profile.1

Brand:

Catelog :

Share :

DESCRIPTIONS

PFO TRIALS REPRESENT A TURNING POINT:

Three large clinical trials have confirmed the superiority of PFO closure to medical management in reducing risk of stroke recurrence. 4 One study, the RESPECT trial, 2 is notable for several reasons:

Excellent safety and efficacy outcomes from the largest PFO trial to date
More patients enrolled and evaluated
The most extensive patient follow-up: 5,810 patient years of data